These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30458163)
21. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease. Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283 [TBL] [Abstract][Full Text] [Related]
24. Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, β-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of Alzheimer's disease. Walker JM; Dixit S; Saulsberry AC; May JM; Harrison FE Neurobiol Dis; 2017 Apr; 100():87-98. PubMed ID: 28108292 [TBL] [Abstract][Full Text] [Related]
25. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes. Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068 [TBL] [Abstract][Full Text] [Related]
26. 1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages. Lalande J; Halley H; Balayssac S; Gilard V; Déjean S; Martino R; Francés B; Lassalle JM; Malet-Martino M J Alzheimers Dis; 2014; 39(1):121-43. PubMed ID: 24145382 [TBL] [Abstract][Full Text] [Related]
28. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice. Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice. Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849 [TBL] [Abstract][Full Text] [Related]
30. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596 [TBL] [Abstract][Full Text] [Related]
31. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease. Wu X; Kosaraju J; Zhou W; Tam KY Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769 [TBL] [Abstract][Full Text] [Related]
33. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease. Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995 [TBL] [Abstract][Full Text] [Related]